What is the Advanced Enzyme Technologies Ltd share price today?

The share price of NSE:ADVENZYMES-EQ on 07 Sep 2026 (as of 10:58:43 IST) is ₹296.55.

What is the NSE:ADVENZYMES-EQ 52 week high low price?

Over the past 52 weeks (as of 07 Sep 2026), the NSE:ADVENZYMES-EQ 52 week high low range shows a high of ₹419.00 and a low of ₹251.95.

What is the Advanced Enzyme Technologies Ltd market cap?

As on 07 Sep 2026, Advanced Enzyme Technologies Ltd market cap is ₹3286.50 Cr.

What is the shareholding pattern of Advanced Enzyme Technologies Ltd Stock?

The shareholding pattern of Advanced Enzyme Technologies Ltd, as of last reported-on 30 Jun 2026 is: Promoters: 43.24% Foreign Institutional Investors (FII): 26.70% Domestic Institutional Investors (DII): 2.95% Mutual Funds: 1.82% Retail & Others: 25.29% This demonstrates an outstanding distribution of ownership.

What are the PE and PB ratios of Advanced Enzyme Technologies Ltd?

The Price-to-Earnings (PE) ratio of Advanced Enzyme Technologies Ltd is 19.81, and the Price-to-Book (PB) ratio is 1.76, as on 07 Sep 2026.

Advanced Enzyme Technologies Share Price

292.75-4.25 (-1.43%)

-12.53% past 1 Year

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

1 Day

-1.43%

1 Week

+1.72%

1 Month

-1.50%

3 Month

-15.96%

6 Month

+10.10%

YTD

-3.14%

1 Year

-12.53%

5 Year

-23.00%

10 Year

-13.84%

Max

+20.97%

YTD

10Y

MAX

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Price Analysis

1 Day

1 Week

1 Month

3 Months

6 Months

1 Year

Low

291.85

287.00

282.05

251.95

High

300.05

302.70

311.00

352.90

419.00

About

Advanced Enzymes Technologies Limited is a research driven company with global leadership in manufacturing of enzymes and probiotics. It is the largest Indian enzyme company engaged in the research and Read more

Pharmaceuticals & Drugs

Smallcap

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats

1. Premium insight available after login

2. Sign in to view full SWOT analysis

3. Unlock strengths, weaknesses, opportunities & threats

QVT

Quality

0/100-

Valuation

0/100-

Technical

0/100-

Peer Stocks

1 week

1 month

1 year

Name

SUNPHARMANSE

DIVISLABNSE

TORNTPHARMNSE

ZYDUSLIFENSE

CIPLANSE

LAURUSLABSNSE

MANKINDNSE

DRREDDYNSE

AUROPHARMANSE

LUPINNSE

ADVENZYMESNSE

LTP

1W Low

1W High

Market cap (₹)

1849.9+12.6 (0.69%)

1832.20

1891.50

4,47,476Cr

9602+227 (2.42%)

9312.50

9740

2,54,764Cr

4928.5+88.5 (1.83%)

4848.50

5010

1,89,423Cr

1180.3+20.3 (1.75%)

1152.10

1190.60

1,16,658Cr

1399+4.5 (0.32%)

1364.50

1419

1,11,484Cr

2026.2+72.2 (3.69%)

1963.80

2055.30

1,09,943Cr

2500+199.3 (8.66%)

2303

2504.30

1,01,712Cr

1200.4+15.4 (1.30%)

1185

1222

1,01,005Cr

1716-18 (-1.04%)

1689.30

1740

99,253Cr

2100.7+17.7 (0.85%)

2080

2135

96,031Cr

293+5.2 (1.81%)

287

302.70

3,326Cr

Advanced Enzyme Technologies Share Price

292.75-4.25 (-1.43%)

-12.53% past 1 Year

Financial overview

Compounded Sales Growth

10 years10%

5 years8%

3 years11%

Last year17%

Compounded Profit Growth

10 years8%

5 years3%

3 years17%

Last year30%

Stock Price CAGR

10 years-1%

5 years-5%

3 years-3%

1 year-13%

Return on Equity

10 years15%

5 years11%

3 years11%

Last year11%

CAGR%

Sales

Profits

Returns

ROE

10Y	5Y	3Y	TTM
10%	8%	11%	17%
8%	3%	17%	30%
-1%	-5%	-3%	-13%
15%	11%	11%	11%

Peer Comparison

Symbol

SUNPHARMA

DIVISLAB

TORNTPHARM

ZYDUSLIFE

CIPLA

LAURUSLABS

MANKIND

DRREDDY

AUROPHARMA

LUPIN

ADVENZYMES

Price	M.Cap (₹)	PE Ratio	EPS (₹)	EV/EBITDA	Annual PAT
1,849.9	₹447476 Cr	37	12.07	62.82	₹11479 Cr
9,602	₹254764 Cr	87.1	34.04	128.41	₹2568 Cr
4,928.5	₹189423 Cr	86.85	16.72	97.06	₹2163 Cr
1,180.3	₹116658 Cr	25.85	9.42	62.53	₹5040 Cr
1,399	₹111484 Cr	33.08	9.77	57.87	₹3879 Cr
2,026.2	₹109943 Cr	100.55	6.8	29.25	₹889 Cr
2,500	₹101712 Cr	49.79	13.75	71.08	₹1913 Cr
1,200.4	₹101005 Cr	31.35	5.32	63.99	₹4196 Cr
1,716	₹99253 Cr	26.73	17.95	96.84	₹3505 Cr
2,100.7	₹96031 Cr	17.37	30.95	154.35	₹5333 Cr
293	₹3326 Cr	20.05	3.31	18.42	₹169 Cr

Profit & Loss

Consolidated

Standalone

Quarterly

Yearly

₹

Balance Sheet

Consolidated

Standalone

₹

Name

Equity And Liabilities

Share Capital

Share Warrants & Outstandings

Total Reserves

Reserve excluding Revaluation Reserve

Shareholder's Funds

Minority Interest

Secured Loans

Unsecured Loans

Deferred Tax Assets / Liabilities

Other Long Term Liabilities

Long Term Provisions

Total Non-Current Liabilities

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Current Liabilities

Total Liabilities

Contingent Liabilities

Total Debt

Assets

Gross Block

Less Accumulated Depreciation

Net Block

Capital Work in Progress

Non Current Investments

Long Term Investment

Long Term Loans & Advances

Other Non Current Assets

Total Non-Current Assets

Current Assets Loans & Advances

Currents Investments

Inventories

Sundry Debtors

Cash and Bank

Other Current Assets

Short Term Loans and Advances

Total Current Assets

Net Current Assets (Including Current Investments)

Total Assets

Book Value

Adjusted Book Value

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹22 Cr	₹22 Cr	₹22 Cr	₹22 Cr	₹22 Cr	₹22 Cr	₹22 Cr	₹22 Cr	₹22 Cr	₹22 Cr	₹22 Cr	₹22 Cr	₹22 Cr	₹22 Cr	₹21 Cr	₹21 Cr
₹9 Cr	₹5 Cr	₹3 Cr	₹0	₹64 L	₹3 Cr	₹4 Cr	₹4 Cr	₹3 Cr	₹30 L	₹0	₹0	₹0	₹0	₹0	₹0
₹1600 Cr	₹1394 Cr	₹1299 Cr	₹1213 Cr	₹1066 Cr	₹946 Cr	₹814 Cr	₹653 Cr	₹534 Cr	₹441 Cr	₹256 Cr	₹190 Cr	₹146 Cr	₹142 Cr	₹76 Cr	₹43 Cr
₹1600 Cr	₹1394 Cr	₹1299 Cr	₹1213 Cr	₹1066 Cr	₹946 Cr	₹814 Cr	₹653 Cr	₹534 Cr	₹441 Cr	₹256 Cr	₹190 Cr	₹146 Cr	₹142 Cr	₹76 Cr	₹43 Cr
₹1632 Cr	₹1421 Cr	₹1324 Cr	₹1235 Cr	₹1089 Cr	₹971 Cr	₹840 Cr	₹679 Cr	₹559 Cr	₹464 Cr	₹278 Cr	₹212 Cr	₹167 Cr	₹163 Cr	₹97 Cr	₹63 Cr
₹51 Cr	₹48 Cr	₹47 Cr	₹49 Cr	₹52 Cr	₹62 Cr	₹28 Cr	₹26 Cr	₹23 Cr	₹21 Cr	₹5 Cr	₹4 Cr	₹4 Cr	₹3 Cr	₹2 Cr	₹1 Cr
₹8 Cr	₹9 Cr	₹7 Cr	₹8 Cr	₹8 Cr	₹10 Cr	₹3 Cr	₹6 Cr	₹17 Cr	₹16 Cr	₹35 Cr	₹49 Cr	₹82 Cr	₹108 Cr	₹132 Cr	₹28 Cr
₹0	₹0	₹0	₹0	₹0	₹18 L	₹72 L	₹1 Cr	₹2 Cr	₹3 Cr	₹4 Cr	₹5 Cr	₹6 Cr	₹8 Cr	₹7 Cr	₹9 Cr
₹27 Cr	₹23 Cr	₹20 Cr	₹26 Cr	₹32 Cr	₹34 Cr	₹25 Cr	₹22 Cr	₹22 Cr	₹12 Cr	₹17 Cr	₹10 Cr	₹6 Cr	₹13 Cr	₹7 Cr	₹7 Cr
₹4 Cr	₹12 Cr	₹16 Cr	₹15 Cr	₹18 Cr	₹4 Cr	₹8 Cr	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0
₹5 Cr	₹2 Cr	₹89 L	₹51 L	₹1 Cr	₹1 Cr	₹1 Cr	₹55 L	₹1 Cr	₹79 L	₹18 L	₹0	₹0	₹0	₹0	₹0
₹44 Cr	₹46 Cr	₹44 Cr	₹49 Cr	₹59 Cr	₹49 Cr	₹39 Cr	₹30 Cr	₹43 Cr	₹32 Cr	₹56 Cr	₹64 Cr	₹94 Cr	₹130 Cr	₹146 Cr	₹44 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹40 Cr	₹19 Cr	₹16 Cr	₹24 Cr	₹18 Cr	₹15 Cr	₹10 Cr	₹10 Cr	₹17 Cr	₹11 Cr	₹12 Cr	₹12 Cr	₹10 Cr	₹17 Cr	₹18 Cr	₹8 Cr
₹48 Cr	₹40 Cr	₹44 Cr	₹43 Cr	₹37 Cr	₹43 Cr	₹34 Cr	₹29 Cr	₹38 Cr	₹21 Cr	₹59 Cr	₹83 Cr	₹60 Cr	₹44 Cr	₹42 Cr	₹7 Cr
₹11 Cr	₹11 Cr	₹18 Cr	₹5 Cr	₹2 Cr	₹5 Cr	₹13 Cr	₹21 Cr	₹38 Cr	₹27 Cr	₹30 Cr	₹24 Cr	₹39 Cr	₹33 Cr	₹38 Cr	₹27 Cr
₹7 Cr	₹25 Cr	₹29 Cr	₹5 Cr	₹4 Cr	₹4 Cr	₹4 Cr	₹5 Cr	₹6 Cr	₹3 Cr	₹10 Cr	₹13 Cr	₹23 Cr	₹7 Cr	₹6 Cr	₹3 Cr
₹107 Cr	₹96 Cr	₹106 Cr	₹78 Cr	₹60 Cr	₹68 Cr	₹60 Cr	₹65 Cr	₹99 Cr	₹62 Cr	₹111 Cr	₹131 Cr	₹133 Cr	₹100 Cr	₹105 Cr	₹45 Cr
₹1834 Cr	₹1611 Cr	₹1521 Cr	₹1411 Cr	₹1260 Cr	₹1149 Cr	₹971 Cr	₹805 Cr	₹727 Cr	₹583 Cr	₹450 Cr	₹412 Cr	₹398 Cr	₹396 Cr	₹349 Cr	₹154 Cr
₹8 Cr	₹9 Cr	₹5 Cr	₹5 Cr	₹13 Cr	₹11 Cr	₹14 Cr	₹29 Cr	₹29 Cr	₹25 Cr	₹19 Cr	₹41 Cr	₹59 Cr	₹10 Cr	₹92 L	₹0
₹21 Cr	₹22 Cr	₹25 Cr	₹13 Cr	₹11 Cr	₹19 Cr	₹26 Cr	₹35 Cr	₹67 Cr	₹54 Cr	₹101 Cr	₹115 Cr	₹167 Cr	₹184 Cr	₹206 Cr	₹65 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹1018 Cr	₹966 Cr	₹902 Cr	₹868 Cr	₹806 Cr	₹756 Cr	₹681 Cr	₹586 Cr	₹561 Cr	₹445 Cr	₹358 Cr	₹346 Cr	₹343 Cr	₹334 Cr	₹244 Cr	₹87 Cr
₹326 Cr	₹287 Cr	₹252 Cr	₹219 Cr	₹187 Cr	₹152 Cr	₹118 Cr	₹91 Cr	₹70 Cr	₹24 Cr	₹72 Cr	₹64 Cr	₹57 Cr	₹47 Cr	₹39 Cr	₹35 Cr
₹692 Cr	₹679 Cr	₹650 Cr	₹649 Cr	₹619 Cr	₹604 Cr	₹563 Cr	₹495 Cr	₹491 Cr	₹421 Cr	₹285 Cr	₹282 Cr	₹286 Cr	₹287 Cr	₹204 Cr	₹51 Cr
₹51 Cr	₹22 Cr	₹31 Cr	₹16 Cr	₹10 Cr	₹5 Cr	₹5 Cr	₹5 Cr	₹3 Cr	₹1 Cr	₹2 Cr	₹5 Cr	₹2 Cr	₹2 Cr	₹60 Cr	₹19 Cr
₹6 L	₹7 L	₹17 L	₹17 L	₹7 L	₹7 L	₹6 L	₹6 L	₹6 L	₹6 L	₹6 L	₹6 L	₹6 L	₹6 L	₹6 L	₹6 L
₹6 L	₹7 L	₹17 L	₹17 L	₹7 L	₹7 L	₹6 L	₹6 L	₹6 L	₹6 L	₹6 L	₹6 L	₹6 L	₹6 L	₹6 L	₹6 L
₹40 Cr	₹24 Cr	₹19 Cr	₹16 Cr	₹18 Cr	₹15 Cr	₹17 Cr	₹11 Cr	₹9 Cr	₹9 Cr	₹18 Cr	₹16 Cr	₹17 Cr	₹12 Cr	₹8 Cr	₹20 Cr
₹6 Cr	₹7 Cr	₹1 Cr	₹1 Cr	₹4 Cr	₹4 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹13 L	₹4 L	₹11 L	₹1 Cr	₹9 L	₹20,000
₹790 Cr	₹731 Cr	₹711 Cr	₹688 Cr	₹656 Cr	₹633 Cr	₹591 Cr	₹518 Cr	₹512 Cr	₹440 Cr	₹311 Cr	₹307 Cr	₹306 Cr	₹302 Cr	₹273 Cr	₹90 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹584 Cr	₹480 Cr	₹403 Cr	₹360 Cr	₹102 Cr	₹121 Cr	₹124 Cr	₹111 Cr	₹40,000	₹40,000	₹0	₹0	₹0	₹0	₹0	₹0
₹177 Cr	₹157 Cr	₹148 Cr	₹124 Cr	₹121 Cr	₹94 Cr	₹80 Cr	₹77 Cr	₹76 Cr	₹68 Cr	₹60 Cr	₹53 Cr	₹50 Cr	₹45 Cr	₹29 Cr	₹18 Cr
₹145 Cr	₹115 Cr	₹99 Cr	₹100 Cr	₹88 Cr	₹86 Cr	₹75 Cr	₹59 Cr	₹59 Cr	₹50 Cr	₹42 Cr	₹37 Cr	₹32 Cr	₹39 Cr	₹32 Cr	₹22 Cr
₹116 Cr	₹108 Cr	₹127 Cr	₹123 Cr	₹274 Cr	₹198 Cr	₹83 Cr	₹23 Cr	₹61 Cr	₹8 Cr	₹26 Cr	₹4 Cr	₹3 Cr	₹4 Cr	₹5 Cr	₹15 Cr
₹9 Cr	₹8 Cr	₹9 Cr	₹6 Cr	₹8 Cr	₹9 Cr	₹8 Cr	₹9 Cr	₹8 Cr	₹3 Cr	₹8 Cr	₹72 L	₹6 L	₹3 L	₹25,573	₹63,269
₹13 Cr	₹11 Cr	₹24 Cr	₹9 Cr	₹12 Cr	₹8 Cr	₹7 Cr	₹3 Cr	₹7 Cr	₹9 Cr	₹3 Cr	₹9 Cr	₹7 Cr	₹7 Cr	₹10 Cr	₹9 Cr
₹1044 Cr	₹880 Cr	₹810 Cr	₹722 Cr	₹604 Cr	₹516 Cr	₹376 Cr	₹282 Cr	₹211 Cr	₹138 Cr	₹140 Cr	₹104 Cr	₹92 Cr	₹94 Cr	₹77 Cr	₹64 Cr
₹937 Cr	₹784 Cr	₹703 Cr	₹645 Cr	₹544 Cr	₹448 Cr	₹316 Cr	₹217 Cr	₹112 Cr	₹76 Cr	₹29 Cr	-₹27 Cr	-₹41 Cr	-₹6 Cr	-₹28 Cr	₹18 Cr
₹1834 Cr	₹1611 Cr	₹1521 Cr	₹1411 Cr	₹1260 Cr	₹1149 Cr	₹971 Cr	₹805 Cr	₹727 Cr	₹583 Cr	₹450 Cr	₹412 Cr	₹398 Cr	₹396 Cr	₹349 Cr	₹154 Cr
₹145	₹127	₹118	₹110	₹97	₹87	₹75	₹60	₹50	₹208	₹128	₹97	₹77	₹75	₹47	₹31
₹145	₹127	₹118	₹110	₹97	₹87	₹75	₹60	₹50	₹42	₹26	₹19	₹15	₹15	₹9	₹6

Cash Flow

Consolidated

Standalone

₹

Name

Profit Before Tax

Adjustment

Changes In working Capital

Cash Flow after changes in Working Capital

Cash Flow from Operating Activities

Cash Flow from Investing Activities

Cash Flow from Financing Activitie

Net Cash Inflow / Outflow

Opening Cash & Cash Equivalents

Cash & Cash Equivalent on Amalgamation / Take over / Merger

Effect of Foreign Exchange Fluctuations

Closing Cash & Cash Equivalent

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011
₹233 Cr	₹187 Cr	₹188 Cr	₹140 Cr	₹171 Cr	₹210 Cr	₹179 Cr	₹162 Cr	₹139 Cr	₹137 Cr	₹118 Cr	₹75 Cr	₹28 Cr	₹77 Cr	₹48 Cr	₹19 Cr
₹4 Cr	₹27 Cr	₹29 Cr	₹37 Cr	₹33 Cr	₹25 Cr	₹28 Cr	₹26 Cr	₹27 Cr	₹18 Cr	₹15 Cr	₹17 Cr	₹21 Cr	₹15 Cr	₹17 Cr	₹6 Cr
-₹15 Cr	-₹12 Cr	-₹26 Cr	-₹34 L	-₹27 Cr	-₹15 Cr	-₹16 Cr	-₹12 Cr	-₹6 Cr	₹4 Cr	-₹13 Cr	-₹12 Cr	₹26 Cr	-₹26 Cr	₹37 Cr	-₹19 Cr
₹222 Cr	₹202 Cr	₹191 Cr	₹177 Cr	₹177 Cr	₹220 Cr	₹192 Cr	₹176 Cr	₹160 Cr	₹160 Cr	₹120 Cr	₹80 Cr	₹75 Cr	₹67 Cr	₹101 Cr	₹6 Cr
₹157 Cr	₹142 Cr	₹141 Cr	₹140 Cr	₹122 Cr	₹163 Cr	₹141 Cr	₹129 Cr	₹116 Cr	₹107 Cr	₹93 Cr	₹54 Cr	₹56 Cr	₹41 Cr	₹88 Cr	₹1 Cr
-₹74 Cr	-₹89 Cr	-₹65 Cr	-₹298 Cr	-₹4 Cr	-₹26 Cr	-₹44 Cr	-₹125 Cr	-₹78 Cr	-₹60 Cr	-₹5 Cr	-₹11 Cr	-₹9 Cr	-₹30 Cr	-₹200 Cr	-₹18 Cr
-₹70 Cr	-₹73 Cr	-₹59 Cr	-₹26 Cr	-₹49 Cr	-₹26 Cr	-₹39 Cr	-₹43 Cr	-₹2 Cr	-₹65 Cr	-₹63 Cr	-₹36 Cr	-₹33 Cr	-₹5 Cr	₹100 Cr	₹30 Cr
₹12 Cr	-₹19 Cr	₹17 Cr	-₹184 Cr	₹70 Cr	₹111 Cr	₹58 Cr	-₹39 Cr	₹36 Cr	-₹18 Cr	₹26 Cr	₹6 Cr	₹13 Cr	₹7 Cr	-₹12 Cr	₹13 Cr
₹94 Cr	₹114 Cr	₹96 Cr	₹267 Cr	₹192 Cr	₹83 Cr	₹23 Cr	₹61 Cr	₹8 Cr	₹25 Cr	₹4 Cr	₹2 Cr	₹3 Cr	₹5 Cr	₹15 Cr	₹2 Cr
₹0	₹0	₹0	₹2 L	₹0	₹60 L	₹0	₹0	₹15 Cr	₹15 L	₹0	₹0	₹0	₹0	₹0	₹0
₹2 Cr	-₹38 L	-₹15 L	₹13 Cr	₹5 Cr	-₹2 Cr	₹2 Cr	₹1 Cr	₹3 Cr	₹39 L	-₹5 Cr	-₹4 Cr	-₹15 Cr	-₹9 Cr	₹2 Cr	₹0
₹109 Cr	₹94 Cr	₹114 Cr	₹96 Cr	₹267 Cr	₹192 Cr	₹83 Cr	₹23 Cr	₹61 Cr	₹8 Cr	₹25 Cr	₹4 Cr	₹2 Cr	₹3 Cr	₹5 Cr	₹15 Cr

Fundamental Ratios

Consolidated

Standalone

Advanced Enzyme Technologies Share Price

292.75-4.25 (-1.43%)

-12.53% past 1 Year

Shareholding summary

Promoters

43.24%

FII

26.7%

DII

2.95%

1.82%

Others

25.29%

Promoters

FII

DII

Others

Quarterly

Yearly

Shareholding Pattern

Quarterly

Yearly

Name

Promoters

FII

DII - Others

DII - MFs

Retail & Others

Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
43.24%	43.26%	43.04%	43.07%	43.08%	43.08%
26.70%	25.50%	25.85%	25.41%	23.45%	11.90%
2.95%	3.48%	3.35%	3.17%	2.99%	2.83%
1.82%	1.93%	2.16%	3.24%	5.46%	5.36%
25.29%	25.83%	25.60%	25.11%	25.02%	36.83%

Bulk & block deals

Name

Polunin Emerging Markets Small Cap Fund Llc

Graviton Research Capital Llp

Motilal Oswal Financial Services Limited

Orbimed Asia Iii Mauritius Limited

Motilal Oswal Financial Services Limited

Orbimed Asia Iii Mauritius Limited

Graviton Research Capital Llp

Deal Date	Action	Deal Value	Deal Price	Qty Traded	Deal Type	%Stake Traded	Exchange
29 Aug 2025	Purchase	44.22 Cr	₹353.50	12.51 L	Bulk	1.117146	NSE
29 Aug 2025	Purchase	35.48 Cr	₹352.13	10.07 L	Bulk	0.899734	NSE
29 Aug 2025	Sell	35.53 Cr	₹352.61	10.07 L	Bulk	0.899734	NSE
11 Sep 2024	Purchase	41.68 Cr	₹507.08	8.22 L	Bulk	0.733975	NSE
11 Sep 2024	Sell	41.70 Cr	₹507.35	8.22 L	Bulk	0.733975	NSE
19 Jun 2024	Purchase	425.55 Cr	₹385	1.11 Cr	Bulk	9.871066	NSE
19 Jun 2024	Sell	425.55 Cr	₹385	1.11 Cr	Bulk	9.871066	NSE
19 Jun 2024	Purchase	425.55 Cr	₹385	1.11 Cr	Block	9.871066	NSE
19 Jun 2024	Sell	425.55 Cr	₹385	1.11 Cr	Block	9.871066	NSE
06 Dec 2023	Purchase	25.87 Cr	₹357.73	7.23 L	Bulk	0.645793	NSE

Insider trading & SAST

Client name

Rahul Shashikant Kirkinde

Amit Kishor Rathi

Leela Kishor Rathi

Ankit Kishor Rathi

Abhijit Kishor Rathi

Vasant Rathi

Reported on	Client category	Action	%Stake traded	Holding % post deal	Deal value	Deal price	Qty traded	Deal period	Deal mode	Post transaction holding	Insider/SAST	Regulation type	Security type
18 May 2026	Designated Person	Disposal	0.003572	0.01	15.18 L	₹379.59	4 K	12 May 2026	Market Sale	5,700	Insider Trading	—	Equity Shares
02 Apr 2026	Immediate Relative	Acquisition	0.013402	0.08	0	—	15 K	30 Mar 2026	Gift	90,001	Insider Trading	—	Equity Shares
02 Apr 2026	Immediate Relative	Disposal	0.040205	0.07	0	—	45 K	30 Mar 2026	Gift	83,000	Insider Trading	—	Equity Shares
02 Apr 2026	Designated Person	Acquisition	0.013402	0.1	0	—	15 K	30 Mar 2026	Gift	1,17,250	Insider Trading	—	Equity Shares
02 Apr 2026	Designated Person	Acquisition	0.013402	0.09	0	—	15 K	30 Mar 2026	Gift	1,00,085	Insider Trading	—	Equity Shares
13 Mar 2026	Promoter & Director	Acquisition	0.016082	26.69	53.72 L	₹298.45	18 K	11 Mar 2026	Market Purchase	2,98,71,702	Insider Trading	—	Equity Shares
10 Mar 2026	Promoter & Director	Acquisition	0.049139	26.61	1.64 Cr	₹297.67	55 K	06 Mar 2026	Market Purchase	2,97,88,702	Insider Trading	—	Equity Shares
10 Mar 2026	Promoter & Director	Acquisition	0.058074	26.67	1.91 Cr	₹293.60	65 K	09 Mar 2026	Market Purchase	2,98,53,702	Insider Trading	—	Equity Shares
10 Mar 2026	Promoter & Director	Acquisition	0.017869	26.57	59.08 L	₹295.38	20 K	05 Mar 2026	Market Purchase	2,97,33,702	Insider Trading	—	Equity Shares
09 Feb 2026	Promoter & Director	Acquisition	0.017869	26.55	58.22 L	₹291.12	20 K	06 Feb 2026	Market Purchase	2,97,13,702	Insider Trading	—	Equity Shares

Advanced Enzyme Technologies Share Price

Price Analysis

Share Price Live Stats

Share Market Cap & Key Ratios Overview

About

Stock Analysis (SWOT)

QVT

Peer Stocks

Advanced Enzyme Technologies Share Price

Advanced Enzyme Technologies Share Price

Financial overview

Compounded Sales Growth

Compounded Profit Growth

Stock Price CAGR

Return on Equity

Peer Comparison

Profit & Loss

Balance Sheet

Cash Flow

Fundamental Ratios

Advanced Enzyme Technologies Share Price

Advanced Enzyme Technologies Share Price

Oscillators

Moving averages

Advanced Enzyme Technologies Share Price

Shareholding summary

Shareholding Pattern

Bulk & block deals

Insider trading & SAST

Advanced Enzyme Technologies Share Price

Corporate Actions

Company details

Advanced Enzyme Technologies Share Price

Corporate filings & documents

Announcements

Annual reports

Concalls & investor presentations

Advanced Enzyme Technologies Share Price

News

Advanced Enzyme gains on completing additional investment of Rs 25 lakh in ANPL

Advanced Enzyme completes additional investment of Rs 25 lakh in ANPL

Advanced Enzyme - Quaterly Results

Advanced Enzymes Outlines FY27 Growth Plans with Wellfa Brand Expansion and US Nutrition Sales Boost

Advanced Enzyme Board Recommends Final Dividend of Rs 1.35 Per Equity Share

Advanced Enzyme Reports Strong Q4 EBITDA Growth to Rs 63.30 Crores, Margin at 31.12%

Advanced Enzyme Technologies Q4 FY25 Net Profit Rises 62% YoY to Rs 43 Cr on 20% Revenue Growth

Advanced Enzyme reports Profit after tax of 22.29 Crores, in the March 2026 quarter

Advanced Enzyme - Quaterly Results

Advanced Enzyme Technologies Q3 FY26 EBITDA Declines YoY to Rs 49.35 Crores, Margin at 28.70%.

Advanced Enzyme Technologies Reports Q3 Revenue Growth of 6.5% YoY to Rs 180 Crores.

Advanced Enzyme Technologies Reports Q3 Net Profit Up 13% YoY to Rs 42.50 Crores.

Advanced Enzyme reports Profit after tax of 13.25 Crores, in the December 2025 quarter

Advanced Enzyme Technologies informs about updates

Advanced Enzyme Technologies informs about trading window closure

Advanced Enzyme guides for FY26 global growth, new specialty launches, capex in India/Mexico.

Advanced Enzyme reports Profit after tax of 22.28 Crores, in the September 2025 quarter

Advanced Enzyme Technologies Q2 FY26 reports 20% YoY revenue growth to Rs 185 crore.

Advance Enzyme Technologies Q2 EBITDA rises to Rs 60 crore, margin expands to 32.55 percent YoY

Advanced Enzyme Technologies posts strong YoY Q2 consolidated net profit growth to Rs 43.40 crores.

Advanced Enzyme Technologies Ltd Share Price Today

Advanced Enzyme Technologies Quick Links

Other Stocks

Calculators

Brokerage Calculator

Stock Average Calculator

MTF Calculator

Margin Calculator

Span Margin Calculator